CD24 and neoplasm: These observations suggest that CD24 can have cell type-specific effects on tumor initiation and growth, a notion supported by our finding that CD24 deficiency slightly but statistically significantly reduced tumor burden in Apc1572T/+ but not MMTV-PyMT mammary carcinomas.